Skip to content

A prospective multi-center hospital cohort study on cognitive impairment longitude evolution in patients with cerebral small vessel disease induced cognitive impairment-no dementia

A prospective multi-center hospital cohort study on cognitive impairment longitude evolution in patients with cerebral small vessel disease induced cognitive impairment-no dementia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017902
Enrollment
Unknown
Registered
2018-08-20
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral small vessel disease

Interventions

Case series:no

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Outpatients and inpatients; 2) Aged 50-80 years old; 3) MRI mainly showing mild to severe white matter damage(Fazekas grades 2,3) , accompanied with lacunar infarcts, cerebral microbleed, enlarged perivascular space. The diagnosis standards by neuroimaging are in accordance with Prevention of Stroke in Patients With Silent Cerebrovascular Disease- A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association; 4) The chief complaint of patients is cognitive impairment, possibly accompanied with affective disorders / sleep disorders/ gait disorder/urinary dysfunction/dysphagia; 5) Objective cognitive assessment showing at least one cognitive domain impairment.

Exclusion criteria

Exclusion criteria: 1) Cortical or large subcortical infarction (>2cm); 2) Intracranial or extracranial macrovascular (>50% stenosis); 3) White matter damage caused by other diseases , including MS/ toxication/ metabolic diseases; 4) Stroke not caused by cerebral small vessel disease; 5) Acute lacunar stroke onset within 3 months; 6) Other clinical manifestations not caused by cerebral small vessel disease, including Parkinson diseases; 7) Cognitive impairments and gait disorders caused by other diseases, including AD/ macrovascular cognitive impairment/ hydrocephalus; 8) Dementia; 9) Severe depression or communicative disorders; 10) Patients unable to sign consent forms and patients with poor compliance; 11) Patients with contraindications for MRI.

Design outcomes

Primary

MeasureTime frame
dementia;cerebral infarction events with area larger than 20mm;death;

Secondary

MeasureTime frame
The score of each scale changes more than one deviation compared with baseline;TIA?minor stroke;

Countries

China

Contacts

Public ContactJianhui Fu

Department of Neurology, Huashan Hospital, Fudan University

jianhuifu@126.com+86 13701818645

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026